Welcome to our dedicated page for Roger news (Ticker: ROG), a resource for investors and traders seeking the latest updates and insights on Roger stock.
Rogers Corporation (NYSE: ROG) is a manufacturing company that focuses on engineered materials used in technology-intensive applications. Its news flow reflects developments in its Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS) segments, which serve markets such as EV/HEV, automotive safety and radar systems, mobile devices, renewable energy, wireless infrastructure, aerospace and defense, energy-efficient motor drives and industrial equipment.
On this page, readers can follow ROG news related to quarterly earnings results, segment performance, restructuring actions and governance changes. Recent press releases have covered first, second and third quarter results, highlighting trends in AES and EMS net sales, gross margin, adjusted earnings per diluted share and adjusted EBITDA, as well as the impact of restructuring and impairment charges. These updates also describe demand patterns across end markets like EV/HEV, ADAS, industrial, portable electronics and wireless infrastructure.
Rogers’ news also includes leadership and board updates, such as the appointment of an interim President and Chief Executive Officer, transitions in the Chair of the Board and plans to add a new independent director with input from an institutional investor. The company issues press releases when it schedules earnings calls, providing details on webcasts where management discusses financial performance, cost initiatives and strategic priorities.
Investors, analysts and other followers of ROG stock can use this news feed to track how Rogers’ engineered materials business is evolving, how its restructuring and cost-reduction programs are progressing and how governance and leadership changes may influence its direction. Bookmark this page to quickly access the latest Rogers Corporation earnings announcements, operational updates and corporate disclosures as they are released.
Rogers Corporation (NYSE:ROG) announced a significant leadership transition as CEO Colin Gouveia has departed, with Ali El-Haj stepping in as interim President and CEO. The Board has initiated a comprehensive search for a permanent CEO, considering both internal and external candidates.
El-Haj brings over 30 years of international experience in automotive and manufacturing industries, most recently leading Techniplas through acquisitions and COVID-19 challenges. His background includes successful leadership roles at CAP-CON Automotive Technologies and Casco Products, along with advanced degrees in physics and engineering.
Rogers Corporation (ROG) reported Q1 2025 financial results with net sales of $190.5 million, showing a slight decrease of 0.9% from the previous quarter. The company posted a net loss of $1.4 million, or $(0.08) per diluted share.
Key highlights:
- Advanced Electronics Solutions sales increased 1.8%, driven by higher ADAS and aerospace/defense sales
- Elastomeric Material Solutions sales decreased 4.3% due to lower portable electronics demand
- Cash position strengthened to $175.6 million
- Gross margin at 29.9%, down from 32.1% in Q4 2024
Looking ahead, Rogers projects Q2 2025 net sales between $190-205 million with gross margins of 31-33%. The company has implemented measures to offset tariff impacts and reduce operating expenses. CEO Colin Gouveia noted limited visibility for the remainder of the year due to global trade uncertainties but emphasized focus on commercial, innovation, and operational priorities.
Rogers (NYSE:ROG) has announced it will release its first quarter 2025 financial results on April 29, 2025, after market close. The company will host a conference call at 5:00 pm ET on the same day.
The earnings call will be led by Colin Gouveia, President and CEO, alongside Laura Russell, Senior Vice President and CFO. Investors can access the live webcast and accompanying slide presentation through Rogers' Investor Relations website at rogerscorp.com/investors, where a replay will also be available.
Rogers is a global leader in engineered materials, specializing in solutions for EV/HEV, automotive safety, radar systems, mobile devices, renewable energy, wireless infrastructure, and energy-efficient motor drives.
Rogers (NYSE:ROG) reported Q4 2024 financial results with net sales of $192.2 million, representing an 8.6% decrease from the previous quarter. The decline was attributed to lower sales in both AES and EMS business units, particularly in wireless infrastructure and industrial sectors.
Gross margin decreased to 32.1% from 35.2% in the prior quarter due to lower volume and unfavorable product mix. GAAP operating margin fell to -2.6% from 6.9%, while adjusted operating margin decreased by 700 basis points to 4.7%. The company reported GAAP earnings per diluted share of $(0.03) compared to $0.58 in the previous quarter, and adjusted earnings of $0.46 per diluted share versus $0.98.
The company ended the quarter with $159.8 million in cash and cash equivalents, an increase of $13.4 million. Net cash provided by operating activities was $33.7 million, with capital expenditures of $15.4 million.
Rogers (NYSE:ROG) has announced it will release its fourth quarter and full year 2024 financial results on February 19, 2025, after market close. The company will host a conference call at 5:00 pm ET on the same day.
The earnings call will be led by Colin Gouveia, President and CEO, alongside Laura Russell, Senior VP and CFO. Investors can access the live webcast and related presentation materials through Rogers' Investor Relations website, where a replay will also be available.
Rogers is a global leader in engineered materials, specializing in solutions for EV/HEV, automotive safety, radar systems, mobile devices, renewable energy, wireless infrastructure, and industrial equipment.
Roche (RHHBY) has received FDA 510(k) clearance for its VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail, a groundbreaking test for diagnosing B-cell lymphoma. This follows its CE Mark approval in June 2024. The test is the first clinically approved in-situ hybridisation (ISH) test capable of assessing all B-cell lymphoma subtypes.
The highly-sensitive test helps distinguish between B-cell cancer and normal immune responses, enabling faster diagnosis and treatment initiation. It can evaluate over 60 B-cell lymphoma subtypes and plasma cell neoplasms on a single tissue slide, working with small biopsies and formalin-fixed tissue. This reduces the need for fresh tissue samples and additional biopsies.
B-cell lymphoma represents about 85% of non-Hodgkin lymphoma (NHL) cases, with NHL being one of the most common cancers in the US, accounting for 4% of all cancer cases and causing over 80,000 deaths annually.
Rogers (NYSE: ROG) has announced the appointment of Woon Keat Moh as an independent member of its Board of Directors, effective January 1, 2025. This addition will expand the Board to nine members, with eight being independent directors. Moh brings nearly 30 years of experience in the specialty materials industry, including significant leadership roles in both Asia and North America. Board Chair Peter Wallace emphasized that Moh's extensive experience in leading global businesses will contribute to Rogers' strategy and shareholder value creation.
Rogers (NYSE: ROG) has appointed Laura Russell as Senior Vice President, Chief Financial Officer and Treasurer, effective December 10. Russell, 49, has been serving as interim CFO since August 2024, following her initial role as Vice President of Finance which she assumed upon joining the company in September 2023.
Prior to Rogers, Russell held key positions including Vice President of Finance, Operations at Wolfspeed (2021-2023) and Vice President of Finance for NXP Semiconductors' Radio Products business (2015-2021). She also worked at Motorola and Freescale Semiconductors from 1997 to 2015. Russell holds a BA in Business Economics from the University of the West of Scotland and is a member of the Chartered Institute of Management Accountants.
Roche has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, the first immunohistochemistry companion diagnostic test in Europe for identifying epithelial ovarian cancer patients eligible for ELAHERE treatment. The test detects folate receptor 1 protein, expressed in about 90% of ovarian carcinomas. This certification follows an early exemption approval in Germany and Austria earlier this year. The test aims to enable more precise treatment decisions for ovarian cancer, which causes 46,232 deaths annually in Europe and is the eighth leading cause of cancer death in women worldwide.
Rogers (NYSE:ROG) reported mixed Q3 2024 results with net sales of $210.3 million, down 1.8% from Q2. Despite lower sales, earnings exceeded guidance due to operational improvements and expense management. GAAP operating margin improved to 6.9% from 5.3%, while adjusted earnings reached $0.98 per diluted share. The company faced softer EV/HEV demand and lower seasonal peak in portable electronics. Looking ahead, Q4 sales are expected to decline due to seasonality and customer inventory management. The company highlighted its expansion with a new power substrate factory in China targeting EV/HEV, renewable energy, and industrial markets.